FDA.reportPublic FDA data

Device Listing 1608074454

Listing Summary#

Listing key
1608074454
Premarket submission
K141771
Device
PROSIGNA BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY
Applicant
Nanostring Technologies, Inc.
Product code
NYI
Decision date
2014-11-07